What is Citius Oncology, Inc.'s interest expense?

Citius Oncology, Inc. (CTOR) reported interest expense of $54.51K in Q3 2025.

What does interest expense mean?

Measures the cost incurred by the company for borrowed funds, including interest on debt, notes payable, and other financial obligations. This reflects the company's leverage and the cost of servicing its capital structure. High interest expenses relative to operating income can indicate financial strain and increased risk for equity holders.

Citius Oncology, Inc. CTOR Interest Expense

Interest Expense at other companies

CHE

ChemedCHE

$512K+55.6%

Tamboran ResourcesTBN

$54K-75.8%

Atlas Lithium CorporationATLX

$160.27K0.0%

Ivanhoe ElectricIE

$1.44M-12.9%

Artesian ResourcesARTNA

$2.23M+2.9%

DJT

Trump Media & Technology GroupDJT

$11.47M+6,040%

Other financials

Income statement

See full

Revenue$1.7M—

Gross profit$1.3M—

Operating income-$28.6M-283%

Net income-$26.6M-244%

EPS (diluted)-$0.27-145%

Balance sheet

See full

Cash & equivalents$2.6M+2,350,466%

Total equity$35.3M-1.0%

Total assets$100.7M+10.1%

Cash flow

See full

Operating cash flow-$3.8M-179%

Valuation

See full

Market cap$60.45M-74.7%

Returns & leverage

See full

Return on equity-119.9%+46.7pp

Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InterestExpense.

The official record: Citius Oncology, Inc.’s 10-K, filed December 23, 2025, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Citius Oncology, Inc.'s interest expense?: Citius Oncology, Inc. (CTOR) reported interest expense of $54.51K in Q3 2025.
What does interest expense mean?: Measures the cost incurred by the company for borrowed funds, including interest on debt, notes payable, and other financial obligations. This reflects the company's leverage and the cost of servicing its capital structure. High interest expenses relative to operating income can indicate financial strain and increased risk for equity holders.